Quarterly Consolidated Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7718086

Concept As at
2018-09-30
As at
2018-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
7,203,000,000 JPY
4,895,000,000 JPY
Securities
851,000,000 JPY
1,217,000,000 JPY
Merchandise and finished goods
1,834,000,000 JPY
1,759,000,000 JPY
Work in process
2,119,000,000 JPY
1,790,000,000 JPY
Raw materials and supplies
4,900,000,000 JPY
5,474,000,000 JPY
Other
599,000,000 JPY
592,000,000 JPY
Current assets
24,148,000,000 JPY
22,831,000,000 JPY
Non-current assets
Property, plant and equipment
10,534,000,000 JPY
10,853,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
4,614,000,000 JPY
4,755,000,000 JPY
Land
3,882,000,000 JPY
3,882,000,000 JPY
Construction in progress
31,000,000 JPY
JPY
Other
Other, net
2,006,000,000 JPY
2,215,000,000 JPY
Intangible assets
Intangible assets
99,000,000 JPY
112,000,000 JPY
Investments and other assets
4,522,000,000 JPY
4,600,000,000 JPY
Investments and other assets
Investment securities
3,227,000,000 JPY
3,194,000,000 JPY
Other
1,320,000,000 JPY
1,429,000,000 JPY
Allowance for doubtful accounts
-24,000,000 JPY
-22,000,000 JPY
Non-current assets
15,156,000,000 JPY
15,567,000,000 JPY
Assets
39,305,000,000 JPY
38,398,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
590,000,000 JPY
585,000,000 JPY
Short-term borrowings
3,530,000,000 JPY
2,893,000,000 JPY
Income taxes payable
646,000,000 JPY
887,000,000 JPY
Other
1,999,000,000 JPY
2,097,000,000 JPY
Current liabilities
7,515,000,000 JPY
7,105,000,000 JPY
Non-current liabilities
Long-term borrowings
1,950,000,000 JPY
2,500,000,000 JPY
Retirement benefit liability
674,000,000 JPY
641,000,000 JPY
Other
218,000,000 JPY
307,000,000 JPY
Non-current liabilities
3,101,000,000 JPY
3,764,000,000 JPY
Liabilities
10,617,000,000 JPY
10,870,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
10,930,000,000 JPY
10,947,000,000 JPY
Retained earnings
11,414,000,000 JPY
10,469,000,000 JPY
Treasury shares
-3,960,000,000 JPY
-4,042,000,000 JPY
Shareholders' equity
27,446,000,000 JPY
26,435,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
653,000,000 JPY
462,000,000 JPY
Foreign currency translation adjustment
163,000,000 JPY
169,000,000 JPY
Remeasurements of defined benefit plans
-57,000,000 JPY
-67,000,000 JPY
Valuation and translation adjustments
758,000,000 JPY
563,000,000 JPY
Share acquisition rights
293,000,000 JPY
344,000,000 JPY
Non-controlling interests
189,000,000 JPY
185,000,000 JPY
Net assets
28,688,000,000 JPY
27,528,000,000 JPY
Liabilities and net assets
39,305,000,000 JPY
38,398,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.